Drug abuse is a significant social problem that can lead to serious obstetric complications, some of which may be confused with pregnancy-related disease states. Substance abuse poses a number of challenges with respect to the management of pain and the conduct of anaesthesia in the peripartum period.
Substance abuse continues to be a problem worldwide and drug abuse in pregnancy is no longer uncommon. In Australia there are estimated to be over 70,000 people dependent on opioids alone, a figure that has doubled in the last 20 years 1 . Nearly 90% of women who are drug abusers are of childbearing age 2 and consequently substance abuse in pregnancy is increasing. A recent case note review in South Australia identified a frequency of substance abuse of 30 per 1000 deliveries, with opioid dependence alone in 11 per 1000 3 . Women dependent on opioids and using illicit drugs present a challenge to the obstetric anaesthetist and place high demands on anaesthetic, pain management and obstetric services during pregnancy and childbirth. A combination of the clinical manifestations of drug abuse, the physiological changes of pregnancy and the pathophysiology of pregnancy-related disease can lead to poor fetal outcomes and serious or even life-threatening maternal complications 4 .
There is a paucity of literature on the management of pain during labour and delivery or in the postpartum period, among women who are tolerant of or addicted to licit or illicit substances. Most of the clinical literature derives from North American populations and the research articles pertain to animal studies. Some authors have specifically addressed the problems of providing anaesthesia and analgesia to the "drug-abusing parturient" 2, 5, 6 .
Others have addressed the management of pain in the methadone-maintained parturient 7, 8 .
Obtaining effective analgesia in the postoperative period, particularly following caesarean section, can be difficult. This is compounded by the failure of many clinicians to appreciate the need for higher than standard drug doses in drug tolerant, dependent or addicted women 7 . Those few reviews addressing the treatment of acute pain among patients with substance abuse disorders have focused mainly on perioperative pain management in opioid dependent patients.
In this paper we discuss the challenges to anaesthetic and pain management services presented by the drug abusing parturient.
MEDICAL DEFINITIONS
The definition of various relevant terms is shown in Table 1 .
With respect to addiction, the word "craving" can be described by any of the following: to have an intense desire for; to need urgently; to beg earnestly for, implore; to have intense desire. Addiction manifests as a pattern of maladaptive behaviours including unwarranted preoccupation with nontherapeutic use and continued use of the drug, despite harm resulting from its use. In isolation, tolerance or physical dependence is not equivalent to "addiction", but either may be associated with addiction 9 . In some cases addiction has an iatrogenic cause, such as inadequately managed pain after surgery or trauma, the inappropriate prescription of opioids or the legitimate use of opioids for persistent pain.
Opioid tolerance is due to neuroadaptive changes including changes in receptor density and coupling to guanine nucleotide binding protein (G-protein) signal transduction pathways. Other proposed mechanisms are up-regulation of cyclic adenosine monophosphate (cAMP) and long-term neuroplasticity adaptations of transcription factorregulating genes, the central glutaminergic system and the spinal dynorphin system 10 . Addiction is associated with down-regulation of the hypothalamic-pituitary adrenal axis. Opioids with a rapid onset of action are believed to pose the greatest risk of addiction in vulnerable individuals 11 .
SUBSTANCE ABUSE AND THE OBSTETRIC PATIENT REQUIRING ANAESTHESIA
Tolerance and/or addiction to drugs and/or alcohol in pregnancy creates many potential problems for the parturient, her fetus or baby, and the obstetricians, anaesthetists, pain specialists, drug and alcohol specialists and neonatologists involved in her care 5 .
Multiple anaesthetic services may be necessary, including antenatal assessment; intravenous access; labour epidural analgesia; anaesthesia for instrumental delivery or caesarean section; antenatal, intrapartum and postpartum pain services and attendance at emergency calls 4 . The obstetric anaesthetist may come across the drug-abusing parturient in a controlled situation, such as a request for labour analgesia, or in an emergency situation, such as placental abruption, uterine rupture or fetal distress. There may be interactions between abused drugs and commonly used anaesthetic agents 6, 12 . Regardless of the drug ingested it is often difficult to predict the exact implications in chemically dependent patients 4 .
At King Edward Memorial Hospital for Women in Perth, Western Australia, between December 1997 and April 2000, 0.76% of all births were to women using opioids and 0.42% to women using amphetamines. Women in both these groups needed more parenteral analgesia during labour and delivery than non-users (P <0.001 for opioids and P <0.05 for amphetamines) 13 . In a U.S. obstetric cohort 14 , 15% of pregnant women had positive urinary drug screens, with drugs detected being alcohol (50%), cigarettes (29%), marijuana (6%), Drug tolerance A predictable pharmacological adaptation manifesting as a state in which there is decreased response to a drug, such that larger doses are required to achieve the same effect 7,10 .
Chemical dependence
A physical and psychological habituation to a mood or mind-altering drug.
Physical dependence
A state in which alterations in the physiological response to a drug lead to an abstinence syndrome on its withdrawal 10 . cocaine (1%) and other drugs (amphetamines, benzodiazepines, toluene-based solvents and caffeine) (8%). Poly-substance abuse in pregnancy is common 15 . Identification of the substance-abusing patient in pregnancy allows carers to optimise management and to prepare for problems. However, up to 70% of women who abuse substances receive little or no antenatal care and some are not identified at all antenatally 16 . Risk factors suggestive of drug use in pregnancy include a lack of antenatal care, cigarette smoking and preterm labour 4, 17, 18 . Lack of antenatal care and assessment may lead to obstetric and anaesthetic problems, the latter particularly in the event of an obstetric emergency, after trauma or at other medical emergencies.
In addition to poor antenatal care, factors to consider in this group of women include an unstable home environment, poor diet and the presence of untreated coexisting disease (for example cellulitis, poor dentition, respiratory infections, untreated abscesses and endocarditis). Difficult peripheral venous access may necessitate central venous cannula placement. The intoxicated parturient can be difficult to assess, aggressive and unwilling to provide consent. There may be unexpected adverse drug reactions or interactions. Universal precautions should be employed when handling body fluids 2 -a review of 85 deliveries in opioid-dependent women in South Australia found 80% were positive for hepatitis C, 9.4% positive for hepatitis B and none for HIV 3 .
In common with most pregnancies, it is accepted that a vaginal delivery with or without regional analgesia is preferable, although with the drug-abusing parturient, specific choices should be made in each individual case when deciding about vaginal birth or regional block 19 . The majority of these women (at least 70%) have a vaginal delivery, and in an Australian cohort of drug abusing parturients 23% used only nitrous oxide for delivery, while 77% used parenteral opioids, regional analgesia or general anaesthesia 13 . Those parturients addicted to substances not affecting opioid receptors will respond to standard doses of pethidine and morphine. However, in women who are dependent on heroin, stabilised on methadone or buprenorphine, are receiving naltrexone, or in whom opioid receptor density and function have been altered by the use of cocaine, regional analgesia is frequently requested during labour. In a South Australian study, 47% of substance abusing women in labour received epidural analgesia (in addition to their usual methadone) 3 . This rate was higher, although not significantly, than that of non-opioid dependent women over the same time period 3 .
Up to 30% of women in tertiary level institutions deliver by caesarean section and this figure is higher in some private obstetric facilities. For these women there is a need to address not only the choice of anaesthesia for delivery, but also analgesia in the postoperative period. There is a greater need for additional analgesic interventions during regional anaesthesia for caesarean section 3 , consistent with a theory of opioid-induced abnormal pain sensitivity ("morphine hyperalgesia"). Substance-abusing patients also have a higher incidence (up to 74%) of inadequate postoperative pain relief after caesarean section 3 . A multimodal approach with intravenous, epidural or intrathecal opioid, paracetamol and a nonsteroidal antiinflammatory drug, in addition to the patient's usual methadone, is recommended. Particular problems are encountered among parturients who are being treated for opioid addiction with opioid antagonists such as naltrexone, especially following a naltrexone implant within the past six to 12 months.
The effects of all concurrent drugs on both mother and fetus must be considered when an anaesthetic is administered. Assessment by an anaesthetist in the third trimester allows discussion of analgesic and anaesthetic options and preparation for potential crises 5 .
DRUG-SPECIFIC ISSUES

Cocaine
Cocaine (benzoylmethylecgonine, C 17 H 21 NO 4 ) is an alkaloid derived from the plant Erythroxylon coca, which is indigenous to South America 20 . The alkalinised form or free base, known as 'crack', has increased bioavailability and is highly addictive 2 . In the U.S.A. it is the most commonly used recreational drug in pregnancy 12 .
Cocaine has local anaesthetic activity and blocks presynaptic uptake of sympathomimetic neurotransmitters (noradrenaline, serotonin and dopamine) resulting in catecholamine accumulation 6, 20 . The euphoric effects result from prolongation of dopaminergic activity in the limbic system and cerebral cortex 20 . Cardiovascular complications, resulting from continued stimulation of the sympatho-adrenal axis by free catecholamine, are not dose-dependent and may occur even after small recreational doses 12 , because such doses can vasoconstrict small epicardial coronary arteries 21 .
Complications such as hypertension, tachycardia, myocardial ischaemia and infarction (caused by thrombosis, embolism or direct myocardial depression 6, 19 ) and arrhythmias may be lifethreatening.
Pregnancy enhances cardiovascular sensitivity to cocaine 22 either because progesterone increases the metabolism of cocaine to a biologically active metabolite, norcaine, or because of a pregnancyrelated increase in alpha-adrenoceptor sensitivity 12 . Maternal complications of cocaine use include placental abruption, uterine rupture, preterm labour, hepatic rupture, cerebral infarction, cardiac arrhythmia and death 2,6 . Cocaine increases all three determinants of myocardial oxygen demand: the heart rate, the systemic resistance and left ventricular contractility, and the risk of myocardial ischaemia or infarction is greater in pregnancy as a result of the increased oxygen demand 19 . Other effects of cocaine include seizures, hyperreflexia, fever, dilated pupils, emotional instability, proteinuria and oedema 20 . Cocaine use may be mistaken for pre-eclampsia or eclampsia 12 , with liver biochemistry and renal function blood tests required to make the distinction 23 .
Cocaine is rapidly transferred across the placenta and thus acts directly on the fetal circulation. Indirect effects on the fetus result from maternal vasoconstriction, uteroplacental insufficiency and compromised oxygenation 6, 19 . A four-fold increase in both preterm delivery and fetal distress syndrome leading to caesarean section has been reported in parturients abusing cocaine during the third trimester of pregnancy 4,6 . Cocaine-related complications may occur even if the last intake of the drug was more than 24 hours earlier 21 .
Both regional and general anaesthesia have been associated with a number of complications in cocaine users 6, 23 . Cocaine-induced thrombocytopenia may contraindicate regional analgesia and anaesthesia 2,6 . Hypertension is a result of vasoconstriction and hypotension due to arrhythmia, myocardial depression or myocardial ischaemia 17 . Ephedrine-resistant hypotension can compromise the fetus and phenylephrine is helpful in this situation 24 . Epidural catheter placement or spinal needle insertion may be difficult in combative, intoxicated patients. Abnormalities in cerebrospinal fluid endorphin levels and changes in mu-and kappa-opioid receptor densities occur in cocaineaddicted patients. This alters pain perception, such that analgesia may prove inadequate despite an adequately functioning epidural or spinal block 25 .
Despite showing its usual efficacy, intrathecal opioid in labour has a shorter duration in cocaine-abusing parturients 26 .
Complications of general anaesthesia in cocaineusing patients include hypertension, myocardial ischaemia and arrhythmias 27 . Halothane sensitises the myocardium to the effects of catecholamines and should be avoided in these patients 6, 28 . Isoflurane has been associated with cardiac arrhythmias and an increased systemic vascular resistance in cocaine-intoxicated patients 29 . There is no information about sevoflurane or desflurane, although neither sensitise the myocardium to catecholamines.
Ketamine increases blood pressure, heart rate and cardiac output due to central stimulation of the sympathetic nervous system, so may potentiate the cardiac effects of cocaine by further elevating catecholamine levels 6, 30 . Prolonged succinylcholine block in a cocaine-using patient has also been reported, presumably as a result of cholinesterase depletion during cocaine metabolism 31 . Propofol and sodium thiopentone are safe and effective for induction of general anaesthesia in these patients 4 . Firm recommendations are not possible, but the cardiovascular effects of cocaine should be considered when choosing appropriate drugs for neuromuscular block and maintenance of anaesthesia.
Pharmacological control of blood pressure prior to laryngoscopy and intubation is recommended to prevent severe hypertension 19 . The treatment of hypertension in cocaine users, however, is not straightforward. Beta-blockers are contraindicated due to the potential for unopposed alpha stimulation and enhanced coronary vasoconstriction 25 . Labetolol, a combined nonselective alpha and beta adrenergic receptor blocker, reduces blood pressure without compromising uterine blood flow or causing tachycardia, although concern has been raised that the beta effect is more predominant than the alpha effect 32 . Hydralazine is a standard treatment for hypertension in these patients but does cause a significant maternal reflex tachycardia 27 . The merit of calcium channel blockers remains unclear as these drugs may prevent the effective treatment of cocaine toxicity 33 . Glyceryl trinitrate and sodium nitroprusside have also been used in this setting but the optimal treatment of hypertension in pregnant cocaine using patients has not been elucidated 12 . Alternative means of diminishing or ablating the sympathetic response to laryngoscopy and intubation are recommended. A number of approaches are appropriate, with a combination of intravenous magnesium sulphate and a rapidly acting opioid such as alfentanil or remifentanil highly effective 34, 35 .
Cocaine-induced coronary artery vasoconstriction, resulting in myocardial ischaemia and chest pain, should be treated with oxygen, glyceryl trinitrate and benzodiazepines. Thrombolytic therapy should only be considered if evidence of myocardial infarction persists despite the above measures (ideally along with angiographic evidence of an occluded artery) and immediate angioplasty is not available 36 .
Amphetamines
Amphetamines are non-catecholamine indirect sympathomimetic drugs that structurally resemble noradrenaline 2 . Methamphetamine ('Ice') and its analogue MDMA (3,4-methylenedioxymethamphetamine, 'Ecstasy') are the most commonly abused amphetamines. Amphetamines are usually used orally but methamphetamine can be used intravenously or smoked.
These drugs affect noradrenaline, serotonin and dopamine neurotransmitter systems and promote release of noradrenaline from presynaptic vesicles, resulting in a profound dose-dependent stimulation of the central nervous system 2 . This leads to increased alertness, euphoria and decreased fatigue. Signs of acute amphetamine ingestion resemble cocaine use and include maternal hypertension, tachycardia, arrhythmias, dilated pupils, hyperreflexia, fever, proteinuria, agitation and confusion 37 . Seizures in pregnancy in the presence of hypertension and proteinuria may be mistaken for eclampsia 38 . The more serious side-effects also mimic the cardiovascular effects of cocaine: hypertension, myocardial ischaemia, cardiac arrhythmias and stroke. Thermoregulatory disturbances leading to heat-stroke fatality may follow MDMA use 39 .
Obstetric emergencies such as fetal distress and placental abruption can be precipitated by amphetamine use and may require emergency caesarean section 4 . Anaesthesia is associated with significant risks. The psychedelic effects of MDMA may affect patient behaviour and interfere with the safe placement of regional blocks 2 . The response to sympathomimetics for the treatment of hypotension in amphetamine users is unpredictable 4 . Cardiac arrest has been reported after both general and regional anaesthesia 40 . As with cocaine abuse, halothane, isoflurane and ketamine are best avoided and the cardiovascular effects of all drugs need to be considered. In animal studies, the acute administration of amphetamine increases the minimal alveolar concentration of volatile inhalation agents 41 , while chronic ingestion decreases the requirement for anaesthetic drugs 42 . In clinical practice the pattern of amphetamine use is often unclear, so anaesthetic drugs should be titrated to effect.
Opioids
Opioid abuse in pregnancy is associated with many problems (Table 2) . Examples are cellulitis, abscesses, sepsis, HIV and AIDS, viral hepatitis, endocarditis and malnutrition 43 . Opioid-abusing women may present with symptoms of overdose or withdrawal. Overdose may cause respiratory depression and respiratory arrest, with or without gastric aspiration. Acute withdrawal syndrome is characterised by increased sympathetic nervous system activity, manifesting as lacrimation, rhinorrhoea, sweating, tachycardia, diarrhoea, restlessness, dehydration, tachypnoea, hypertension and insomnia 44 . Regional anaesthesia is a safe alternative in the opioid-addicted woman provided there is no haemodynamic instability, coagulopathy, sepsis or other contraindication. An increased incidence of spinal, epidural and disc space infection has been reported in intravenous drug addicts, but is independent of type of anaesthesia 45 . This warrants high levels of surveillance and early microbiological diagnosis and therapy of infection. Being HIV positive is not a contraindication to central regional block. Given that the central nervous system is infected early in the course of the disease, concern about seeding the virus from a regional technique is unfounded 46 . Liver disease and malnutrition may require dose adjustment of anaesthetic drugs 4 .
The acute administration of opioids decreases general anaesthetic requirements but chronic use may increase tolerance to anaesthetic drugs and other CNS depressants 4 . Intravenous access for parturients who have used intravenous drugs may be difficult and necessitate central venous access. This poses a particular challenge if an aggressive opioid addicted patient is vomiting while experiencing drug withdrawal during labour.
Methadone maintenance therapy poses less risk to the mother and fetus than intravenous opioid and methadone is currently recommended for the treatment of opioid-addicted patients in pregnancy 8, 45 . Methadone is a synthetic opioid with a half-life of 12 to 100 hours, usually 25 to 30 hours in long-term users. Oral administration provides ready and reliable absorption, avoiding the peaks and troughs of plasma concentration associated with intravenous heroin use and blocking cravings for 24 to 36 hours 7,8 . It is generally agreed that pregnant patients should receive as high a maintenance dose of methadone as is required to prevent heroin use 6 . The dose may need to be increased in the third trimester as the physiological changes of pregnancy (slowed gastrointestinal absorption, expanded fluid volume and increased glomerular filtration rate) and placental metabolism change the pharmacokinetic profile 7,8 . Divided doses, without an increase in total dose, may reduce withdrawal symptoms and trough levels can be estimated to assist with dosing regimens 8 .
Common issues in the management of pain among parturients on methadone include the assumption that the dose taken for maintenance is sufficient to provide adequate analgesia; that the usual daily dose of methadone should be omitted while the patient is in labour and that giving another opioid with the methadone may precipitate respiratory depression. If the methadone-dependent patient is in pain, aberrant drug behaviour may occur 7 .
Effective analgesia in opioid-dependent patients requires careful attention to clinical and pharmacological principles 2 . A management plan for labour and delivery should be established and the parturient seen regularly for pain management as well as obstetric assessment 8 . Epidural analgesia is preferable to systemic opioid analgesia, since adequate doses are difficult to predict and achieve. To avoid acute opioid withdrawal during labour, replacement of the patient's usual opioid dose with an equivalent dose of oral, parenteral or epidural opioid is suggested, in addition to providing new dose requirements 8, 47, 48 Although methadone is an effective analgesic, alternative mu-opioid receptor agonists for the treatment of acute pain are preferred to clearly distinguish between the treatment of addiction and the treatment of pain 7 . In addition, the slow onset of action and long half-life of methadone make it difficult to titrate it rapidly enough to control acute pain 7 . The stable dose of methadone, used as maintenance therapy, actually provides no clinically meaningful analgesic effect to the patient. Methadone maintained patients have lowered pain thresholds and lower pain tolerance than other individuals 49 , perhaps due to the decreased production of endogenous opioids. Consequently, patients receiving methadone maintenance therapy for addiction often receive suboptimal treatment of acute pain, because clinicians mistakenly believe that the chronic methadone dose will provide adequate analgesia when higher then average doses of additional opioid may be necessary 7, 8 . Opioid antagonists may precipitate acute withdrawal and should be avoided at all costs 8 . Symptoms of opioid withdrawal can be treated with non-opioid medications such as clonidine, doxepin and diphenhydramine 50, 51 .
If operative delivery occurs, either neuraxial opioids or a multimodal analgesic approach including titrated systemic opioid (for example, patientcontrolled intravenous fentanyl) can be used to manage the temporarily increased requirements 10, 52 .
The infant of the opioid-dependent woman requires high level neonatal care. The risk of neonatal abstinence syndrome, which most commonly is delayed until the second or third day of life, is high in women using heroin or methadone (70 to 80%) and less but still a common problem in those on buprenorphine 53 .
In the postpartum phase the maternal methadone dose can be reduced to pre-pregnancy levels or for women taking methadone for a pregnancy-related pain problem, a gradual withdrawal plan instituted. This involves a reduction in dose on a regular basis, usually a week apart, with smaller reductions as the dose approaches zero 8 .
Buprenorphine has been registered in Australia since 2001 for opioid substitution for maintenance therapy in individuals with opioid dependence, although it is not registered for use in pregnancy 1 . Buprenorphine is a partial agonist with strong receptor affinity that attenuates opioid analgesia, causing difficulties in achieving labour and postoperative pain relief 1 . Neuraxial analgesic techniques are valuable and regional and multimodal analgesic regimens that maximise nonopioid analgesia should be employed 1, 10 . If patientcontrolled analgesia is considered appropriate, provision should be made for larger bolus doses and use of a background infusion, and higher rates of intervention and dose adjustment are likely 3 .
There is preliminary evidence to show that naltrexone implants can be used in the pregnant heroin user without risk to either mother or fetus 54 . These implants pose very significant problems for pain management in the parturient, with responses to high doses of mu-opioid receptor agonists dependent on the duration of the implant and thus plasma levels of naltrexone. Rapid opioid detoxification under general anaesthesia has not yet been evaluated for safety in pregnant patients 55 .
Solvents
Solvents encompass a range of substances that affect the central nervous system, including organic solvents and volatile agents. The inhalation of toluene, an industrial solvent used in household paints and cleaning agents 2 , results in loss of inhibition and central nervous system stimulation similar to that seen with alcohol 56 . Distortion of perception to sensory stimuli, loss of coordination, nausea, headache and vomiting and respiratory compromise are other effects. Toluene may change autonomic cardiac function, leading to ventricular fibrillation and myocardial infarction 57 . Chronic exposure to toluene vapour produces brain atrophy and cerebellar degeneration 58 . Acute respiratory distress, increased airway resistance, pulmonary hypertension, adult respiratory distress syndrome and liver toxicity have also been reported in pregnant women exposed to solvents 59 . A neurological examination to determine pre-existing sensory or motor deficits should be performed before initiating regional anaesthesia or analgesia 60 .
Tobacco
Despite well-proven adverse effects, 80% of women who smoke before conception continue to do so during pregnancy 61 . Regional anaesthesia or analgesia are suitable and avoid some of the potential adverse effects of general anaesthesia (bronchospasm, reduced mucociliary clearance and postoperative pulmonary morbidity) among parturients who smoke 12 . Cigarette smoking increases mucous production, diminishes ciliary transport and induces small airway dysfunction and impairment of gas exchange 62 . Four to six weeks abstinence is needed to decrease postoperative respiratory morbidity to that similar to a non-smoker, although mucociliary function probably recovers within a few days of cessation 62 . The affinity of haemoglobin for carbon monoxide is 200 times that for oxygen, which results in decreased oxygen delivery to maternal and fetal tissues 63 . Carboxy-haemoglobin levels, which are as high as 10% in smokers, decrease toward those of non-smokers (<1%) after 48 hours of abstinence. Cigarette smoke may also affect hepatic microsomal enzymes and alter the metabolism of intravenous induction agents 2 .
Marijuana
Marijuana derives from the plant Cannabis sativa and is one of the most commonly used illicit drugs among women of childbearing age 4 . Delta-9-tetrahydrocannabinol (THC) is the most potent psychoactive component 4 and also causes euphoria, conjunctival congestion and anxiety 64 . Cardiovascular effects include myocardial depression and tachycardia, interacting with anaesthetic drug effects on heart rate and blood pressure 4 . During general anaesthesia there may be pronounced myocardial depression 65 . Marijuana enhances the sedating and hypnotic effects of other central nervous system drugs and there may be cross-tolerance with opioids, benzodiazepines and barbiturates 66 . Drugs such as ketamine, pancuronium, atropine and adrenaline, which increase the heart rate, should be avoided 4 . After heavy use lung function may be impaired similarly to tobacco smoking 4 . Oropharyngitis and uvular oedema causing airway obstruction under general anaesthesia have been reported in marijuana smokers 67 .
Ethanol
Pregnant patients with a history of alcohol abuse often present with a multitude of related Anaesthesia and Intensive Care, Vol. 35, No. 6, December 2007 or additional problems at the time of labour and delivery. Acute intoxication increases the risk of maternal pulmonary aspiration and fetal distress. Chronic alcohol use may lead to liver disease, poor nutrition, coagulopathy, pancreatitis, cardiomyopathy, oesophageal varices and altered drug metabolism 12 . Acute withdrawal from alcohol presents with nausea, vomiting, tachycardia, arrhythmias, hypertension, delirium, hallucinations, confusion, seizures and cardiac failure 68 . Such symptoms appear six to 48 hours after cessation of alcohol consumption, although delays of up to 10 days have been reported 5 . Withdrawal symptoms may be suppressed by benzodiazepines, alpha 2 -adrenoceptor agonists such as clonidine, or resumption of alcohol intake.
Regional anaesthesia or analgesia can be safely used in the alcohol-dependent parturient provided coagulopathy, neuropathy and infection are excluded 69 . If general anaesthesia is required, chronic alcohol intake does not alter the requirement, pharmacokinetics or pharmacodynamics of thiopentone 70 , but the presence of liver or cardiac failure will require appropriate adjustment of drugs and technique 2 . The risk of aspiration is higher due to increased gastric acid secretion and decreased protective airway reflexes 69 .
Benzodiazepines
There are few data on benzodiazepine abuse during pregnancy and although this does not appear common, it may be part of poly-substance abuse. Implications for the fetus and neonate include an increased risk of congenital malformation with excessive intake in the first trimester and near the time of delivery, neonatal withdrawal symptoms and the 'floppy infant syndrome', characterised by mild sedation, hypotonia, reluctance to suck, apnoeic spells and impaired metabolic response to cold stress 71 .
Anaesthetic requirements may be increased in these women and the parturient entering a withdrawal syndrome is likely to be agitated and tachycardic.
Gamma-hydroxybutyrate
Gamma-hydroxybutyrate (GHB) (sodium oxybutyrate; 'liquid X', 'liquid ecstasy', 'grievous bodily harm -GBH', 'salty water') is a naturally occurring short-chain fatty acid found in mammalian brain tissue that produces dosedependent sedation and anaesthesia in humans 72 .
GHB is metabolically derived from gammaaminobutyric acid (GABA) and acts as a neuromodulator 73 .
GHB was first synthesised in the 1960s and has been used as a growth promoter by bodybuilders, as a sleep enhancer, and clinically in the treatment of narcolepsy and alcohol withdrawal 72, 74, 75 . Although introduced as an anaesthetic induction drug in 1964, it has become obsolete because of the high incidence of myoclonic seizures and vomiting 75 . GHB was available as a legal dietary supplement in the US until 1990, after which adverse effects and abuse were reported. By 1990, due to its euphoric effects, GHB had become a recreational 'club drug' 76 , and was implicated in episodes of drug-facilitated sexual assault 72, 74 . In the U.S. a national probability survey of 466 hospitals in 21 metropolitan areas (Drug Abuse Warning Network) found the mention of GHB in emergency department documentation had increased from 56 occasions in 1994 to 3,340 times in 2001 77 .
Recreationally GHB is often used in combination with other drugs such as ecstasy, cannabis, cocaine, amphetamines and alcohol to prolong the 'high' 78 . Symptoms associated with recreational GHB use include euphoria, somnolence, confusion, aggression, ataxia, increased libido, enhancement of tactile sensation, urinary incontinence, increased gag reflex, nausea and vomiting 74 . Oral doses of 10 mg/kg produce short-term amnesia and hypotonia, 20 to 30 mg/kg induces sleep and drowsiness, while 50 to 60 mg/kg induces anaesthesia and is associated with hypotonia, nystagmus, bradycardia, hypotension, vomiting, mild hypothermia, bradypnoea and Cheyne-Stokes respiration. Severe cardiorespiratory depression, coma and seizures occur at higher doses 74, 75 .
Overdose is common, with 75% of regular Australian users experiencing at least one accidental overdose 79 . GHB withdrawal may occur within 90 minutes of the last dose and when dramatic, comprises tremor, sweating, tachycardia, agitation, insomnia, hypertension, nausea and vomiting, and auditory and visual hallucinations 74 . GHB is not routinely tested for during drug screens and its short half-life and absence of toxic metabolites reduces the duration of detectability 74, 76 .
There are no reports in the literature of GHB use in pregnancy or of implications related to anaesthesia. However, acute use may lead to respiratory depression necessitating respiratory drug abuse in pregnanCy and anaesThesia Anaesthesia and Intensive Care, Vol. 35, No. 6, December 2007 support and chronic use may lead to withdrawal. No specific antidotes are available and treatment is supportive.
Ketamine and hallucinogens
Ketamine, well known as an anaesthetic drug, has become popular as a 'club' drug. Other hallucinogens include lysergic acid diethylamide (LSD), phencyclidine (PCP, from which ketamine is derived), psilocybin (in 'magic mushrooms') and mescaline 76 . Phencyclidine acts on nicotinic acid receptors as well as N-methyl-D-aspartate receptors and produces similar effects to ketamine 80 . The hallucinogens are taken orally (ketamine also intramuscularly or intravenously) and cause auditory, visual and tactile hallucinations, anxiety and panic attacks 4 .
Ketamine produces an 'out of body experience' and has dissociative effects, whereas phencyclidine produces violent erratic behaviour with increased pain tolerance and ataxia 76 . These drugs activate the sympathetic nervous system causing tachycardia, hypertension, elevated temperature and dilated pupils 4, 76 . The effects of acute ingestion develop over one to two hours and last approximately 12 hours 76 . Addiction and an abstinence syndrome have been described 81 . Dissociation of the cortex from the limbic system results in hallucinations, psychotic reactions, catecholamine release and increased muscle tone 80, 82 . Users are at risk of hypertension during stimulation and psychotic behaviour 82 . Overdose may cause respiratory depression, seizures, coma and death; increases in cardiac output and heart rate may precipitate coronary ischaemia 76 .
Phencyclidine use in pregnancy is associated with fetal growth restriction (32%), premature labour and delivery (43%), meconium stained amniotic fluid (30%) and neonatal withdrawal syndrome (27%) 83 . These drugs induce hyperthermia, so increased maternal and fetal oxygen consumption raises the possibility of fetal heat-induced neurological injury 4 . Most of these drugs are used in combination with other drugs and alcohol potentiates many of their side-effects. Treatment of intoxication is supportive 4, 76 .
Anaesthesia may precipitate a postoperative panic response in hallucinogen-abusing patients 44 . During anaesthesia the risk of autonomic dysregulation is high and wide swings in blood pressure and tachycardia should be anticipated and prevented, to reduce the risk of cardiomyopathy, coronary and cerebral vasospasm 76 . An exaggerated response to sympathomimetic drugs and arrhythmias is common 4 , so caution should be exercised when using ephedrine 4 . Hallucinogens can prolong the analgesic and ventilatory depressant effects of opioids 4, 76 . Both LSD and PCP may prolong the effects of succinylcholine due to reduced plasma cholinesterase activity 4 . Hypertension and proteinuria with or without seizures has been mistaken for pre-eclampsia or eclampsia 76 . Routine liver and renal function tests, and urine toxicology, may help rule out one or other of the diagnoses.
Tramadol
Tramadol, a 4-phenyl-piperidine analogue of codeine, is an inhibitor of noradrenaline and serotonin reuptake with some mu-opioid receptor agonist activity. It is considered a safe drug that is devoid of many of the serious adverse effects of opioids 84 . Although rare, it does carry a risk of dependence and abuse, even among patients with no history of drug abuse. Although considered a non-habit and non-dependence forming analgesic, abstinence/withdrawal symptoms have been reported following abrupt cessation of chronic tramadol intake 85 . Fatal intoxication may occur and those with a history of substance abuse are at increased risk 84 .
Abstinence symptoms include restlessness, insomnia, hallucinations, extreme anxiety, panic attacks and unusual sensory experiences, diarrhoea, abdominal cramps, musculoskeletal pain and restless leg syndrome 85, 86 . Tramadol is associated with seizures, in particular when used concomitantly with other drugs which lower the seizure threshold 87 and during pregnancy this may be confused with eclampsia.
SUMMARy
Drug abuse remains a significant problem in our society and can result in serious obstetric complications. Some of these complications may be confused with pregnancy-related disease states. Substance abuse poses a number of challenges with respect to the management of pain and the conduct of anaesthesia in the peripartum period (Tables 2 and 3 ). Given that almost 80% of substance-abusing parturients require the services of an anaesthetist in the perinatal period, early antenatal referral for anaesthetic review is recommended to plan anaesthesia or analgesia 3 . It is essential that obstetricians, general practitioners and midwives identify the substance-abusing Opioid-dependent women in particular benefit from an antenatal plan for labour and postoperative analgesia and those parturients recovering from drug addiction should also have a well-documented strategy of pain management 68 . A multidisciplinary approach will involve the obstetricians, anaesthetists and staff of the Drug and Alcohol Service 3 . For acute obstetric admissions where no antenatal care has been accessed, a high index of suspicion for illicit drug use should arise. Because illicit substance use is so prevalent in our society, if untoward reactions occur during an otherwise uneventful anaesthetic, the possibility of drug abuse should be considered 4 .
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